D
Sight Sciences, Inc. SGHT
$5.14 -$0.14-2.65% NASDAQ
Recommendation
Prev Close
$5.28
Volume
4,892
Avg Vol (90D)
149,821
Market Cap
$276.50M
Dividend & Yield
--
52-Week Range
$2.03 - $5.48
P/E (TTM)
--
EPS (TTM)
-$0.96
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Sight Sciences, Inc. (NASDAQ:SGHT) Given Average Recommendation of "Hold" by Analysts
10/27/2025 - MarketBeat
Sight Sciences (NASDAQ:SGHT) Given "Sell (D-)" Rating at Weiss Ratings
10/26/2025 - MarketBeat
Sight Sciences to Report Third Quarter 2025 Financial Results on November 6, 2025
10/23/2025 - GuruFocus
Sight Sciences to Report Third Quarter 2025 Financial Results on November 6, 2025
10/23/2025 - Globe Newswire
Sight Sciences (SGHT): Lake Street Raises Price Target to $7.00 SGHT Stock News
10/21/2025 - GuruFocus
Sight Sciences price target raised to $7 from $5 at Lake Street
10/21/2025 - TipRanks Financial Blog
Sight Sciences price target raised by $2 at Lake Street, here's why
10/21/2025 - The Fly
The volume for Sight Sciences stock increased for one day, resulting in a record-breaking daily growth of 451% of the 65-Day Volume Moving Average
10/21/2025 - Tickeron - Stocks
UBS Remains a Buy on Sight Sciences (SGHT)
10/20/2025 - TipRanks Financial Blog
Market Participants Recognise Sight Sciences, Inc.'s (NASDAQ:SGHT) Revenues Pushing Shares 37% Higher
10/18/2025 - Simply Wall St
Sight Sciences (SGHT, $4.69) RSI Indicator left the overbought zone on October 17, 2025
10/18/2025 - Tickeron - Technical Analysis
Sight Sciences Shares Jump 32% On Medicare Pricing Update For TearCare System
10/17/2025 - RTT News - Momentum Stocks
Sight Sciences (SGHT) Gains Pricing Approval from Medicare Contractors
10/17/2025 - GuruFocus
Sight Sciences to provide updated revenue guidance on Q3 earnings call
10/17/2025 - The Fly
Sight Sciences announces fee schedule establishment for TearCare procedure
10/17/2025 - The Fly
Sight Sciences Announces Fee Schedule Establishment from Novitas Solutions and First Coast Service Options for the TearCare Interventional Dry Eye Procedure
10/17/2025 - Globe Newswire
Sight Sciences (SGHT, $3.33) Aroon Indicator entered a Downtrend on October 14, 2025.
10/15/2025 - Tickeron - Stocks
Sight Sciences (SGHT, $3.26) Aroon Indicator entered a Downtrend on October 13, 2025.
10/14/2025 - Tickeron - Technical Analysis
Sight Sciences (SGHT, $3.2) Moving Average Convergence Divergence (MACD) Histogram turned negative on October 10, 2025
10/11/2025 - Tickeron - Stocks
Sight Sciences (SGHT, $3.2) Aroon Indicator entered a Downtrend on October 10, 2025.
10/11/2025 - Tickeron - Stocks
Sight Sciences (SGHT, $3.38) Aroon Indicator entered a Downtrend on October 09, 2025.
10/10/2025 - Tickeron - Stocks
Sight Sciences (NASDAQ:SGHT) Earns Sell (D-) Rating from Weiss Ratings
10/9/2025 - MarketBeat
Sight Sciences (SGHT, $3.47) Aroon Indicator entered a Downtrend on October 08, 2025.
10/9/2025 - Tickeron - Stocks
Add Up The Parts: DFUS Could Be Worth $80
10/8/2025 - ETF Channel
Sight Sciences (SGHT, $3.47) Aroon Indicator entered a Downtrend on October 07, 2025.
10/8/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
$76.30M
EBITDA (TTM)
-$48.08M
EBIT (TTM)
-$48.68M
Net Income (TTM)
-$49.01M
Balance Sheet
Total Assets (Q)
$121.97M
Total Debt (Q)
$40.57M
Total Liabilities (Q)
$51.96M
Book Value Per Share (Q)
$1.35
Cash Flow
Cash from Operations (TTM)
-$22.25M
Cash from Investing (TTM)
-$398.00K
Cash from Financing (TTM)
$5.97M
Net Change in Cash (TTM)
-$16.68M
Filings
Filing Date
Thursday, August 7, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 3 and 7 (est)
Price History
Loading...
Beta
2.04
7-Day Total Return
48.99%
30-Day Total Return
46.02%
60-Day Total Return
57.19%
90-Day Total Return
20.37%
Year to Date Total Return
43.58%
1-Year Total Return
-1.15%
2-Year Total Return
42.38%
3-Year Total Return
-30.63%
5-Year Total Return
--
52-week Low
Apr 08, 2025 - $2.03
52-week High
Oct 30, 2024 - $5.48
Valuation
Market Cap
$276.50M - Micro Cap
Enterprise Value
$215.57M
Price/Sales (TTM)
3.59
Price/Book (Q)
3.92
Dividends and Shares
Shares Outstanding
51.82
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.sightsciences.com
Phone Number
877 266 1144
Address
4040 Campbell Avenue
Menlo Park, CA 94025
Country
United States
Year Founded
2010
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases... more
NASDAQ 10/27/2025 10:58AM Eastern Quotes delayed